LACRIFLOW CL - The Lacriflow CL is indicated in treatments of - KANEKA CORPORATION

Duns Number:690535406

Device Description: The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, i The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of:- Canalicular pathologies (stenosis, obstruction, lacerations),- During Dacryocystorhinostomy (conventional or laser),- Congenital nasolacrimal duct obstruction.

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

-

Brand Name

LACRIFLOW CL

Version/Model Number

LF-CL105A

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

K170247,K170247

Product Code Details

Product Code

OKS

Product Code Name

Lacrimal Stents And Intubation Sets

Device Record Status

Public Device Record Key

edd4ddd2-41a4-47cf-8730-7b6cfe7bc899

Public Version Date

December 11, 2019

Public Version Number

5

DI Record Publish Date

June 01, 2017

Additional Identifiers

Package DI Number

14540778171388

Quantity per Package

2

Contains DI Package

04540778171381

Package Discontinue Date

-

Package Status

In Commercial Distribution

Package Type

-

"KANEKA CORPORATION" Characteristics
Device Class Device Class Description No of Devices
2 A medical device with a moderate to high risk that requires special controls. 1041
U Unclassified 1